Chile - español - ISPC (Instituto de Salud Pública de Chile)

l'oreal chile s.a. - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

comcait s.a. - sin formulas

Cuba - español - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

importadora y manufacturera bruluart s.a.. - diclofenaco sódico; clorhidrato de tiamina (vitamina b1); clorhidrato de piridoxina (vitamina b6); cianocobalamina (vitamina b12) - solución para inyección im - 100 mg/ml; 100 mg/ml; 5 mg/ml; 75 mg/2 ml

Cuba - español - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

importadora y manufacturera bruluart s.a.. - clorhidrato de tiamina (vitamina b1); clorhidrato de piridoxina (vitamina b6); acetato de hidroxocobalamina (eq. a hidroxocobalamina: vitamina b12); lidocaína (eq. a 2,133 mg de clorhidrato de lidocaína) - solución para inyección im - 100 mg; 50 mg; 10 mg; 2 mg

Cuba - español - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

importadora y manufacturera bruluart s.a.. - clorhidrato de tiamina; clorhidrato de piridoxina; hidroxocobalamina (eq. a 10,443 mg de acetato de hidroxocobalamina) - solución para inyección im - 100 mg; 50 mg; 10 mg

Unión Europea - español - EMA (European Medicines Agency)

virbac s.a. - interferón omega recombinante de origen felino - inmunoestimulantes, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. en gatos infectados por vif, la mortalidad fue baja (5%) y no fue influenciada por el tratamiento.

Unión Europea - español - EMA (European Medicines Agency)

intervet international b.v. - asociado a células vivas recombinantes turquía virus del herpes (cepa hvp360), que expresan la proteína de fusión de nd virus y la proteína vp2 de la eii virus - aviar, el virus del herpes (enfermedad de marek) + aviar enfermedad de gumboro virus (enfermedad de gumboro) + enfermedad de newcastle virus/paramixovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Unión Europea - español - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - inmunológicos para aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Unión Europea - español - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - cerdos - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.